These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38170528)

  • 1. Understanding the social risk factor adjustment's effect on Star Ratings.
    Tolpadi A; Sorbero ME; DeYoreo M; Elliott MN; Damberg CL
    Am J Manag Care; 2023 Dec; 29(12):e372-e377. PubMed ID: 38170528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjusting Medicare Advantage star ratings for socioeconomic status and disability.
    Sorbero ME; Paddock SM; Damberg CL; Haas A; Kommareddi M; Tolpadi A; Mathews M; Elliott MN
    Am J Manag Care; 2018 Sep; 24(9):e285-e291. PubMed ID: 30222924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Medicare Advantage Star Ratings With Racial, Ethnic, and Socioeconomic Disparities in Quality of Care.
    Meyers DJ; Rahman M; Mor V; Wilson IB; Trivedi AN
    JAMA Health Forum; 2021 Jun; 2(6):e210793. PubMed ID: 35977175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Medicare Advantage Prescription Drug Plan Star Ratings on Enrollment before and after Implementation of Quality-Related Bonus Payments in 2012.
    Li P; Doshi JA
    PLoS One; 2016; 11(5):e0154357. PubMed ID: 27149092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between Medicare Advantage contract characteristics and quality-of-care ratings: an observational analysis of Medicare Advantage star ratings.
    Xu P; Burgess JF; Cabral H; Soria-Saucedo R; Kazis LE
    Ann Intern Med; 2015 Mar; 162(5):353-8. PubMed ID: 25732277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Relationship Between Medicare Advantage Star Ratings and Enrollee Experience.
    Meyers DJ; Rahman M; Wilson IB; Mor V; Trivedi AN
    J Gen Intern Med; 2021 Dec; 36(12):3704-3710. PubMed ID: 33846937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is There a Relationship Between Part D Medication Adherence and Part C Intermediate Outcomes Star Ratings Measures?
    Ta JT; Erickson SC; Qiu WA; Patel BV
    J Manag Care Spec Pharm; 2016 Jul; 22(7):787-95. PubMed ID: 27348279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of low-income subsidy, medicaid dual eligibility, and disability status with high-risk medication use among Medicare Part D beneficiaries.
    Chinthammit C; Bhattacharjee S; Lo-Ciganic WH; Axon DR; Slack M; Bentley JP; Warholak TL
    Res Social Adm Pharm; 2022 Apr; 18(4):2634-2642. PubMed ID: 34006485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between integrated and non-integrated plans in Medicare Advantage.
    Park S; Langellier BA; Meyers DJ
    Health Serv Res; 2023 Jun; 58(3):560-568. PubMed ID: 36376095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multichannel Medication Adherence Intervention Influences Patient and Prescriber Behavior.
    Leslie RS; Gilmer T; Natarajan L; Hovell M
    J Manag Care Spec Pharm; 2016 May; 22(5):526-38. PubMed ID: 27123914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher Medicare Advantage Star Ratings Are Associated With Improvements In Patient Outcomes.
    Meyers DJ; Trivedi AN; Wilson IB; Mor V; Rahman M
    Health Aff (Millwood); 2021 Feb; 40(2):243-250. PubMed ID: 33523734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there an association between the high-risk medication star ratings and member experience CMS star ratings measures?
    Erickson SC; Leslie RS; Patel BV
    J Manag Care Spec Pharm; 2014 Nov; 20(11):1129-36. PubMed ID: 25351974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Income-related disparities in Medicare advantage behavioral health care quality.
    Breslau J; Haviland AM; Klein DJ; Martino S; Adams J; Dembosky JW; Tamayo L; Gaillot S; Overton Y; Elliott MN
    Health Serv Res; 2023 Jun; 58(3):579-588. PubMed ID: 36579742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Drivers of Disenrollment and Plan Switching Among Medicare Advantage Beneficiaries.
    Meyers DJ; Belanger E; Joyce N; McHugh J; Rahman M; Mor V
    JAMA Intern Med; 2019 Apr; 179(4):524-532. PubMed ID: 30801625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Higher Generic Drug Use and Medicare Part D Star Ratings: An Observational Analysis.
    Hohmann N; Hansen R; Garza KB; Harris I; Kiptanui Z; Qian J
    Value Health; 2018 Oct; 21(10):1186-1191. PubMed ID: 30314619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Cumulative Disenrollment in the Medicare Advantage Program, 2011-2020.
    Meyers DJ; Ryan AM; Trivedi AN
    JAMA Health Forum; 2023 Aug; 4(8):e232717. PubMed ID: 37624613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of star ratings bonus payments on disparities in medication utilization issues.
    Tsang CCS; Garuccio J; Dong X; Sim Y; Wang J
    Explor Res Clin Soc Pharm; 2023 Sep; 11():100323. PubMed ID: 37694164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Supplemental Benefits and Plan Ratings Among Medicare Advantage Enrollees.
    Tucher EL; Meyers DJ; Trivedi AN; Gottlieb LM; Thomas KS
    JAMA Netw Open; 2024 Jun; 7(6):e2415058. PubMed ID: 38837157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of an integrated adherence program aimed to increase Medicare Part D star rating measures.
    Leslie RS; Tirado B; Patel BV; Rein PJ
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1193-203. PubMed ID: 25443513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Medicare Advantage plan star ratings and enrollment.
    Reid RO; Deb P; Howell BL; Shrank WH
    JAMA; 2013 Jan; 309(3):267-74. PubMed ID: 23321765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.